patient data
Description
This study investigates the additional impact of Leap Motion-based VR therapy, when used alongside conventional treatment, on the upper extremity function, physical activity and participation of stroke patients. Forty post-stroke patients were randomly assigned to either a control (CG) or an experimental group (EG). Both groups received 60 minutes of CT, while the EG received additional 40 minutes of VR therapy, five days a week for four weeks. Outcome measures included the Fugl-Meyer Assessment for Upper Extremity (FMA-UE), Selective Control of the Upper Extremity Scale (SCUES), Nine-Hole Peg Test (NHPT), Disabilities of the Arm, Shoulder and Hand questionnaire (DASH-T), and Stroke-Specific Quality of Life Scale (SS-QOL). Outcome assessments were performed by an independent assessor at baseline (T0), post-intervention (4 weeks,T1), and at 1 (T2)- and 3 (T3)-month follow-ups. Patient demographic data and assessment results for each time period are presented individually in Excel.
Files
Steps to reproduce
Outcome assessments were performed by an independent assessor at baseline (T0), post-intervention (4 weeks,T1), and at 1 (T2)- and 3 (T3)-month follow-ups. Due to the nature of the intervention, participants and treating occupational therapists were not blinded.